bioRxiv Science⌕ Search

Biology subjects

Park, G. H.

Publications and source records attributed to Park, G. H..

2 recordsLinked to original sources

Ubiquitin-specific protease 20 promotes CCCP-induced mitophagy through deubiquitination and stabilization of serine/threonine protein kinase PINK1

While Parkinsons disease (PD) is predominantly sporadic, various mutations in the PTEN-induced putative kinase 1 (PINK1) gene have been linked to the autosomal recessive form of PD. PINK1, a serine/threonine protein kinase, holds a pivotal role in mitophagy - a process that selectively eliminates damaged mitochondria, overseeing mitochondrial quality control and ultimately safeguarding against neuronal cell loss in PD. Understanding the regulation of PINK1 stability is essential in comprehending PD pathology, given its involvement in a pro-survival pathway. Although some components of the ubiquitin-proteasome system (UPS) are recognized for mediating the proteolysis of PINK1, the specific enzyme(s) responsible for positively influencing PINK1 stability have remained elusive. In this study, we demonstrated that ubiquitin-specific protease 20 (USP20) functions as a novel deubiquitinating enzyme targeting PINK1. We found that USP20 positively regulates PINK1 levels by hydrolyzing Lys 48-linked polyubiquitin chains, promoting mitophagy under the treatment of mitochondrial depolarizing agent carbonyl cyanide m-chlorophenyl hydrazine (CCCP). Furthermore, CCCP treatment accelerates the deubiquitinating activity of USP20, facilitating the degradation of impaired mitochondria and enhancing mitochondrial quality control via PINK1 accumulation. Taken together, these findings unveil a novel enzyme, USP20, positively impacting PINK1 level and promoting CCCP-induced mitophagy. In addition, this study establishes a comprehensive map depicting how PINK1 can be regulated both positively and negatively through the coordinated action of multiple members in the UPS.

cell biology↗

RNF213 variant and autophagic impairment: A pivotal link to endothelial dysfunction in Moyamoya disease

BackgroundMoyamoya disease (MMD) is closely associated with the Ring Finger Protein 213 (RNF213), a susceptibility gene for this disease. However, its biological function remains unclear. We aimed to elucidate the role of RNF213 in the damage incurred by human endothelial cells under oxygen-glucose deprivation (OGD), a condition that mimics intracranial ischemia in patients with MMD. MethodsWe analyzed autophagy in peripheral blood mononuclear cells (PBMCs) derived from patients carrying either RNF213 wild-type (WT) or variant (R4810K). Subsequently, human umbilical vein endothelial cells (HUVECs) were transfected with RNF213 WT (HUVECWT) or R4810K (HUVECR4810K) and exposed to OGD for 2 h to determine the role of the RNF213 variant in such a setting. Immunoblotting was used to analyze autophagy marker proteins, and tube formation assays were performed to examine endothelial function. Autophagic vesicles were observed using transmission electron microscopy. Post-OGD exposure, we administered autophagy modulators such as rapamycin and cilostazol. ResultsThe RNF213 variant group during post-OGD exposure (vs. pre-OGD exposure) showed autophagy inhibition, increased protein expression of SQSTM1/p62 (p < 0.0001) and LC3-II (p = 0.0039), and impaired endothelial function (p = 0.0252). HUVECR4810K during post-OGD exposure (versus pre-OGD exposure) showed a remarkable increase in autophagic vesicles. Administration of autophagy modulators notably restored the function of HUVECR4810K and cellular autophagy. ConclusionsOur findings support the pivotal role of autophagy impaired by the RNF213 variant in MMD-induced endothelial cell dysfunction and underscore the critical mechanism of autophagy leading to progressive endothelial dysfunction and MMD pathogenesis under relative ischemia within the intracranial portion.

neuroscience↗